Targeted Protein Degradation Market Size Worth USD 3547.91 million by 2034 | CAGR: 20.7%

𝐓𝐡𝐞 𝐭𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝐝𝐞𝐠𝐫𝐚𝐝𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟓𝟒𝟏.𝟗𝟖 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒. 𝐈𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 𝟑𝟓𝟒𝟕.𝟗𝟏 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟒, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟐𝟎.𝟕% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟓 𝐭𝐨 𝟐𝟎𝟑𝟒.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧:
Targeted protein degradation (TPD) utilizes the body's natural mechanisms as a therapeutic strategy to eliminate specific proteins in cells. TPD medications utilize tiny molecules to interact with the cellular ubiquitin-proteasome system, tagging specific proteins for breakdown. This approach offers a promising remedy for addressing diseases caused by defective or overly active proteins, opening up a new path for developing drugs, especially for difficult conditions like cancer and neurodegenerative diseases.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/targeted-protein-degradation-market/request-for-samplev

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:
● The rise in the use of TPD technologies in oncology is predicted to be a significant trend in the TPD market in the coming time.
● There is an increasing emphasis on utilizing TPD technologies for the treatment of neurological disorders. Proteins linked to neurodegenerative diseases like Alzheimer's and Parkinson's are now being focused on more for breaking down in order to help with symptoms or delay the progression of the disease.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
In a highly competitive environment, leading competitors continually strive to innovate and distinguish their products to gain a competitive advantage in the market. Here is the list of the leading companies operating in the targeted protein degradation market:

• Arvinas
• Kymera Therapeutics
• Nurix Therapeutics
• C4 Therapeutics
• Foghorn Therapeutics
• Zymeworks
• Bristol-Myers Squibb
• Pfizer
• AbbVie
• Molteni Farmaceutici

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
The targeted protein degradation market is mainly segmented based on type, therapeutic area, route of administration, and region. Based on type analysis, the proteolysis-targeting chimeric molecules (PROTACs) segment accounted for the largest market share and recorded the highest growth rate. PROTACs are becoming increasingly popular because they use two-in-one molecules to precisely degrade specific proteins, making them effective in targeting various disease-related proteins.

Moreover, according to the therapeutic area analysis, the oncological disorders segment accounted for the largest market share and is anticipating the highest growth. This growth is credited to the major progress in cancer studies and the rising amount of tailored treatments created to target different cancer-related proteins.

By Type Outlook (Revenue - USD Million, 2020-2034)
• Degronimids
• Immunomodulatory Drugs (IMiDs)
• Proteolysis-Targeting Chimeric Molecules (PROTACs)
• Sudden Acquired Retinal Degeneration Syndrome
(SARDs)
• Selective Estrogen Receptor Degraders (SERDs)
• Others

By Therapeutic Area Outlook (Revenue - USD Million, 2020-2034)
• Inflammatory Disorders
• Neurological Disorders
• Oncological Disorders
• Respiratory Disorders
• Others

By Route of Administration Outlook (Revenue - USD Million, 2020-2034)
• Oral
• Intravenous
• Others

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
https://www.polarismarketresearch.com/buy/4216/0

𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:
o North America (U.S., Canada)
o Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
o Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
o Latin America (Brazil, Mexico, Argentina)
o Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Peripheral Vascular Device Market
https://www.polarismarketresearch.com/industry-analysis/global-peripheral-vascular-device-market

Psoriasis Drug Market
https://www.polarismarketresearch.com/industry-analysis/global-psoriasis-drug-market

Psoriatic Arthritis Market
https://www.polarismarketresearch.com/industry-analysis/global-psoriatic-arthritis-market

Hematologic Malignancies Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/hematologic-malignancies-therapeutics-market

Osteoarthritis Market
https://www.polarismarketresearch.com/industry-analysis/global-osteoarthritis-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.